Nerve Repair and Re-Generation Market, By Surgery (Nerve Grafting, Neurorrhaphy), By Product (Biomaterials Neurostimulation & Neuromodulation Device), and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Trends, Analysis and Forecast till 2034

Report Code: PMI255619 | Publish Date: February 2024 | No. of Pages: 178

Global Nerve Repair And ReGeneration Overview

Nerve Repair and Regeneration Market was valued at US$ 10 Billion in 2024 and is projected to grow at a CAGR of 12.30% to reach US$ 31.7 Billion by 2034.Nerve Repair is a complex biological process which begins immediately following the nerve injury, while neuro-generation is the regrowth of nervous tissue by generating new axons, neurons, synapses glial cells.

Global Nerve Repair And ReGeneration Dynamics

Drivers

Restrains

Availability of various therapies for treating Alzeihmer’s and Parkinson’s disease

Rising surgical complications

Increasing cases of neurological disorders

Stringent regulations

Presence of major companies and strong pipeline

Product recalls

Access Crucial Insights at a Fraction of the Cost | Request Your Discount

Global Nerve Repair And ReGeneration Segmentation

The target market is segmented based on Surgery, Product, and Region.

Surgery Insight

On the basis of Surgery, the target market is segmented Nerve Grafting, Neurorrhaphy.

Product Insight

On the basis of Product, the target market is segmented into Biomaterials Neurostimulation & Neuromodulation Device.

Regional Insights:

On region the target market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.

North America market is estimated to witness a significantly high revenue share over the forecast period.

  • Rising incidence of neurological disorders
  • Adoption of advanced technological devices
  • Presence of major market players such as Boston Scientific, Medtronic plc.
  • Continuous technological development

Asia Pacific market is estimated to witness a fastest revenue share over the forecast period.

  • Rapidly growing population
  • Rising government initiative
  • Adoption of innovative technologies
Reduce costs by up to 30% with a custom report tailored to your specific needs | Request Customized Report

Recent Development:

             The New Launched Product News,

  • In July 2023, U.S. FDA (Food and Drug Administration) approved “Lenire” a non-invasive bi-modal neuro-modulation device developed by Neuromod Devices, a medical technology company based in Ireland. The device is designed to treat tinnitus a complex neurological condition which creates perception of sound without external source.
  • In November 2022, CVRx launched new version of neuromodulation device which is designed to treat symptoms of heart failure in patients. The new ‘Barostim NEO2’ device are compatible with new IPG model and thus, offers streamlined design with single lead port to simplify implant procedure.
  • In June 2021, Medtronic plc, received FDA (Food and Drug Administration) approval for its Vanta, a high performance recharge-free INS (implantable neurostimulator) device with shelf life of 11 years. It offers twice the device life than primary cell devices.
  • In August 2019, OMRON Healthcare launched an Electronic Nerve Stimulator (model HV-F013) which is equipped with OMRON’s TENS (Transcutaneous Electrical Nerve Stimulation) technology in India. The new device is designed for home use and thus, provides drug-free pain relief.
  • In April 2016, St. Jude Medical Inc., announced the U.S. launch of “Axium Neurostimulator System” for DRG (dorsal root ganglion) stimulation for treating patients with chronic pain which has been harder in controlling with traditional spinal cord stimulation.

 

Report Scope:

Attribute

Details

Base year for estimation

2023

Forecast period

2024 – 2034

Market representation

Revenue in USD Billion & CAGR from 2024 to 2034

Market Segmentation

By Surgery  - Nerve Grafting, Neurorrhaphy

By Product - Biomaterials Neurostimulation & Neuromodulation Device

Regional scope

North America - U.S., Canada

Europe - UK, Germany, Spain, France, Italy, Russia, Rest of Europe

Asia Pacific - Japan, India, China, South Korea, Australia, Rest of Asia-Pacific

Latin America - Brazil, Mexico, Argentina, Rest of Latin America

Middle East & Africa - South Africa, Saudi Arabia, UAE, Rest of Middle East & Africa

Report coverage

Revenue forecast, company share, competitive landscape, growth factors, and trends

Segments Covered in the Report:

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2024 to 2034.

Few Other Promising Reports:

Global Nerve Repair And ReGeneration Key Players

The key players operating the target market includes, AxoGen Inc., Baxter International, Boston Scientific Incorporation, Cyberonics Inc., Integra Lifesciences Corporation, Medtronic plc, Orthomed S.A.S., Polyganics B.V., Jude Medical, Stryker Corporation, and others.

Global Nerve Repair And ReGeneration Table of Contents

Research Objective and Assumption

  • Preface
  • Research Objectives
  • Study Scope
  • Years Considered for the study
  • Assumptions
  • Abbreviations

Research Methodology

  • Research data
  • Primary Data
    • Primary Interviews
    • Primary Breakdown
    • Key data from Primary Sources
    • Key Thickness Insights
  • Secondary Data
    • Major Secondary Sources
    • Secondary Sources
  • Market Estimation
  • Top-Down Approach
    • Approach for estimating Market Share by Top-Down Analysis (Supply Side)
  • Bottom-Up Approach
    • Approach for estimating market share by Bottom-up Analysis (Demand Side)
  • Market Breakdown and Data Triangulation
  • Research Assumptions

Market Preview

  • Executive Summary
  • Key Findings—Global Outlook for medical carts Strategies
    • Key Questions this Study will Answer
    • Market Snippet, By Surgery
    • Market Snippet, By Product
    • Market Snippet, By Region
  • Opportunity Map Analysis
  • Executive Summary—3 Big Predictions

Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restrains
    • Market Opportunities
    • Market Trends
  • DR Impact Analysis
  • PEST Analysis
  • Porter’s Five Forces Analysis
  • Opportunity Orbit
  • Market Investment Feasibility Index
  • Macroeconomic Factor Analysis

Nerve Repair and Re-Generation Market, By Surgery, Forecast Period up to 10 Years, (US$ Bn)

  • Overview
    • Market Value and Forecast (US$ Bn), and Share Analysis (%), Forecast Period up to 10 Years
    • Y-o-Y Growth Analysis (%), Forecast Period up to 10 Years
    • Segment Trends
  • Nerve Grafting
    • Overview
    • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
  • Neurotheraphy
    • Overview
    • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years

Nerve Repair and Re-Generation Market, By Product, Forecast Period up to 10 Years, (US$ Bn)

 

  • Overview
    • Market Value and Forecast (US$ Bn), and Share Analysis (%), Forecast Period up to 10 Years
    • Y-o-Y Growth Analysis (%), Forecast Period up to 10 Years
    • Segment Trends
  • Biomaterials Neurostimulation
    • Overview
    • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
  • Neuromodulation Device
    • Overview
    • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years

Nerve Repair and Re-Generation Market, By Region, Forecast Period up to 10 Years, (US$ Bn)

  • Overview
    • Market Value and Forecast (US$ Bn), and Share Analysis (%), Forecast Period up to 10 Years
    • Y-o-Y Growth Analysis (%), Forecast Period up to 10 Years
    • Regional Trends
  • North America
    • Market Size and Forecast (US$ Bn), By Surgery, Forecast Period up to 10 Years
    • Market Size and Forecast (US$ Bn), By Product, Forecast Period up to 10 Years
    • Market Size and Forecast (US$ Bn), By Country, Forecast Period up to 10 Years
      • U.S.
      • Canada
  • Europe
    • Market Size and Forecast (US$ Bn), By Surgery, Forecast Period up to 10 Years
    • Market Size and Forecast (US$ Bn), By Product, Forecast Period up to 10 Years
    • Market Size and Forecast (US$ Bn), By Country, Forecast Period up to 10 Years
      • UK
      • France
      • Germany
      • Russia
      • Italy
      • Rest of Europe
  • Asia Pacific
    • Market Size and Forecast (US$ Bn), By Surgery, Forecast Period up to 10 Years
    • Market Size and Forecast (US$ Bn), By Product, Forecast Period up to 10 Years
    • Market Size and Forecast (US$ Bn), By Country, Forecast Period up to 10 Years
      • India
      • Japan
      • South Korea
      • China
      • Rest of Asia Pacific
  • Latin America
    • Market Size and Forecast (US$ Bn), By Surgery, Forecast Period up to 10 Years
    • Market Size and Forecast (US$ Bn), By Product, Forecast Period up to 10 Years
    • Market Size and Forecast (US$ Bn), By Country, Forecast Period up to 10 Years
  • Brazil
  • Mexico
  • Rest of Latin America
  • Middle East & Africa
    • Market Size and Forecast (US$ Bn), By Surgery, Forecast Period up to 10 Years
    • Market Size and Forecast (US$ Bn), By Product, Forecast Period up to 10 Years
    • Market Size and Forecast (US$ Bn), By Country, Forecast Period up to 10 Years
  • GCC
  • Israel
  • South Africa
  • Rest of Middle East

Competitive Landscape

  • Heat Map Analysis
  • Market Presence and Specificity Analysis

Company Profiles

  • AxoGen Inc.
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • Baxter International
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • Boston Scientific Incorporation
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • Cyberonics Inc
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • Integra Lifesciences Corporation
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • Medtronic plc
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • Orthomed S.A.S.
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • Polyganics B.V.
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • Jude Medical
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • Stryker Corporation.
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  1. The Last Word
    • Future Impact
    • About Us
    • Contact

FAQs

The rapidly growing population, rising prevalence of neurological diseases and improved healthcare infrastructure in emerging economies such as India, Brazil and China has offered lucrative opportunities in market growth. Further, the emerging stem cell therapy technology in nerve repair generation is expected to boost the demand for market growth.

By region, the target market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The North America market is estimated to witness a significantly high revenue share over the forecast period.

The key players operating the target market includes, AxoGen Inc., Baxter International, Boston Scientific Incorporation, Cyberonics Inc., Integra Lifesciences Corporation, Medtronic plc, Orthomed S.A.S., Polyganics B.V., Jude Medical, Stryker Corporation, and others.